BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6809782)

  • 1. Chronic pulsatile low dose GnRH therapy for induction of testosterone production and spermatogenesis in a man with secondary hypogonadotropic hypogonadism.
    Skarin G; Nillius SJ; Wibell L; Wide L
    J Clin Endocrinol Metab; 1982 Oct; 55(4):723-6. PubMed ID: 6809782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of spermatogenesis by intranasal administration of gonadotropin-releasing hormone in patients with hypothalamic hypogonadism.
    Klingmüller D; Schweikert HU
    J Clin Endocrinol Metab; 1985 Nov; 61(5):868-72. PubMed ID: 3930553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
    Klingmüller D; Menger D; Wildt L; Leyendecker G; Krück F; Schweikert HU
    Horm Metab Res; 1985 Jul; 17(7):358-61. PubMed ID: 3928472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C; Tso SC; Todd D
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Wang X; Zheng JJ; Liu ZX; Xu HL; Huang BK; Nie M; Wu XY
    Asian J Androl; 2018; 20(4):319-323. PubMed ID: 29516878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulsatile luteinizing hormone-releasing hormone treatment of male hypogonadotropic hypogonadism.
    Aulitzky W; Frick J; Galvan G
    Fertil Steril; 1988 Sep; 50(3):480-6. PubMed ID: 3137102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile GnRH treatment in boys and girls with idiopathic hypogonadotrophic hypogonadism.
    Delemarre-Van de Waal HA; Odink RJ
    Hum Reprod; 1993 Nov; 8 Suppl 2():180-3. PubMed ID: 8276956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
    Smith R; Donald RA; Espiner EA; Stronach SG; Edwards IA
    J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Induction of spermatogenesis by pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadism].
    Christiansen P; Krabbe S; Skakkebaek NE
    Ugeskr Laeger; 1992 Feb; 154(6):348-9. PubMed ID: 1539368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of male hypogonadotropic hypogonadism and constitutional delay of puberty by pulsatile administration of gonadotropin-releasing hormone.
    Partsch CJ; Hermanussen M; Sippell WG
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1196-203. PubMed ID: 3923024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism--diagnostic and therapeutic aspects.
    Delemarre-van de Waal HA
    Eur J Endocrinol; 2004 Nov; 151 Suppl 3():U89-94. PubMed ID: 15554892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in anterior pituitary response in patients with idiopathic hypothalamic hypogonadism caused by pulsatile GnRH therapy and testosterone replacement.
    Schopohl J; Mojto J; Losa M; Mehltretter G; Müller OA; von Werder K
    Exp Clin Endocrinol Diabetes; 1995; 103(3):184-90. PubMed ID: 7584521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic hypogonadotropic hypogonadism in men: dependence of the hormone responses to gonadotropin-releasing hormone (GnRH) on the magnitude of the endogenous GnRH secretory defect.
    Barkan AL; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1118-25. PubMed ID: 3932448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive follicle-stimulating hormone responses to intravenous gonadotropin-releasing hormone in boys with idiopathic hypogonadotropic hypogonadism.
    Padmanabhan V; Kelch RP; Sonstein J; Foster CM; Beitins IZ
    J Clin Endocrinol Metab; 1988 Oct; 67(4):793-800. PubMed ID: 3138278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
    Sheckter CB; McLachlan RI; Tenover JS; Matsumoto AM; Burger HG; de Kretser DM; Bremner WJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of spermatogenesis and biological paternity by intranasal (low dose) gonadotropin-releasing hormone (GnRH) in a male with Kallmann's syndrome: intraindividual comparison of GnRH and gonadotropins for stimulation of spermatogenesis.
    Oppermann D; Happ J; Mayr WR
    J Clin Endocrinol Metab; 1987 Nov; 65(5):1060-6. PubMed ID: 3312278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
    Huang Q; Mao J; Wang X; Yu B; Ma W; Ji W; Zhu Y; Zhang R; Sun B; Zhang J; Nie M; Wu X
    Endocr Pract; 2022 May; 28(5):521-527. PubMed ID: 35218954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.